AlphaYouJR
Insider selling
James R. Kasinger sold $626K of CRISPR Therapeutics AG (CRSP) stock
James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics AG (CRSP), sold 10,400 shares of CRSP stock worth $626K, per an SEC Form 4 filed Sep 24, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 22, 2026, 2 days before it was made public.
CRSP has moved -5.5% since the trade date, from $59.03 to $55.76 (Sep 23, 2026 close).
- Traded
- Sep 22, 2026
- Disclosed
- Sep 24, 2026
- Filing delay
- 2 days
- Price since
- -5.5%
- Role
- General Counsel and Secretary
- Source
- SEC Form 4
More CRSP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.